DEVELOPMENT OF SPECIFIC INHIBITORS FOR BREAST CANCER-ASSOCIATED VARIANTS OF ERBB2

$302,303FY2014Department of the ArmyDOD

The Research Foundation For The State University Of New York

Investigators